Clinical trial
Assessment of the eFficacy, the Onset-of-Action and the Safety of Tot'héma® in Adults With Moderate Iron Deficiency Anaemia
NCT04309669 is registered in ClinicalTrials.gov with Laboratoire Innotech International as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of the eFficacy, the Onset-of-Action and the Safety of Tot'héma® in Adults With Moderate Iron Deficiency Anaemia
- Lead sponsor
- Laboratoire Innotech International
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 12, 2020
- Completion date
- October 6, 2023
- Enrollment
- 167 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.